FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2160696211> ?p ?o ?g. }

• W2160696211 endingPage "70" @default.
• W2160696211 startingPage "65" @default.
• W2160696211 abstract "We analyzed the beneficial therapeutic effect of angiotensin converting enzyme inhibitor (ACEI) on both retinal and hind limb neovascularization in diabetic mice.Diabetic mice (streptozotocin, 40 mg/kg) were treated with or without ACEI (Perindopril, 3 mg/kg per day) or AT1 receptor blocker (Candesartan, 20 mg/kg) for 4 months. Hind limb ischemia was then induced by right femoral artery ligature for 1 additional month. In the ischemic leg, angiographic score, capillary density, and foot perfusion were increased by 2.7, 2.0-fold, and 1.6-fold, respectively, in ACEI-treated diabetic mice compared with untreated diabetic animals (P<0.01). ACEI also raised vascular endothelial growth factor (VEGF) protein level by 1.4-fold in ischemic diabetic leg. This ACEI pro-angiogenic effect was totally blunted in diabetic bradykinin B2 receptor-deficient animals, suggesting that it was mediated by the bradykinin pathway. In the diabetic retina, angiotensinogen and ACE mRNA levels were increased by 2.8-fold and 4.1-fold, respectively (P<0.01 versus nondiabetic mice), highlighting a local activation of renin-angiotensin system. Diabetes also raised VEGF protein level by 1.5-fold (P<0.05 versus nondiabetic mice). Treatments with ACEI and AT1 receptor blocker hampered diabetes-induced VEGF upregulation and retinal neovascularization.ACE inhibition improved neovascularization in the diabetic ischemic leg through activation of bradykinin signaling, whereas it reduced vessel growth in the diabetic retina through inhibition of overacting Ang II pathway." @default.
• W2160696211 created "2016-06-24" @default.
• W2160696211 creator A5016057578 @default.
• W2160696211 creator A5026377797 @default.
• W2160696211 creator A5034436745 @default.
• W2160696211 creator A5036965490 @default.
• W2160696211 creator A5074641512 @default.
• W2160696211 creator A5089583231 @default.
• W2160696211 date "2005-01-01" @default.
• W2160696211 modified "2023-09-27" @default.
• W2160696211 title "Dual Effect of Angiotensin-Converting Enzyme Inhibition on Angiogenesis in Type 1 Diabetic Mice" @default.
• W2160696211 cites W1983251348 @default.
• W2160696211 cites W1994936867 @default.
• W2160696211 cites W202302843 @default.
• W2160696211 cites W2039284766 @default.
• W2160696211 cites W2042761977 @default.
• W2160696211 cites W2043909669 @default.
• W2160696211 cites W2044437167 @default.
• W2160696211 cites W2049796621 @default.
• W2160696211 cites W2053184382 @default.
• W2160696211 cites W2053713685 @default.
• W2160696211 cites W2055769896 @default.
• W2160696211 cites W2063924458 @default.
• W2160696211 cites W2075582632 @default.
• W2160696211 cites W2098767125 @default.
• W2160696211 cites W2127083467 @default.
• W2160696211 cites W2142041241 @default.
• W2160696211 cites W2149471545 @default.
• W2160696211 doi "https://doi.org/10.1161/01.atv.0000149377.90852.d8" @default.
• W2160696211 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15528473" @default.
• W2160696211 hasPublicationYear "2005" @default.
• W2160696211 type Work @default.
• W2160696211 sameAs 2160696211 @default.
• W2160696211 citedByCount "105" @default.
• W2160696211 countsByYear W21606962112012 @default.
• W2160696211 countsByYear W21606962112013 @default.
• W2160696211 countsByYear W21606962112014 @default.
• W2160696211 countsByYear W21606962112015 @default.
• W2160696211 countsByYear W21606962112016 @default.
• W2160696211 countsByYear W21606962112017 @default.
• W2160696211 countsByYear W21606962112018 @default.
• W2160696211 countsByYear W21606962112019 @default.
• W2160696211 countsByYear W21606962112020 @default.
• W2160696211 countsByYear W21606962112021 @default.
• W2160696211 countsByYear W21606962112022 @default.
• W2160696211 countsByYear W21606962112023 @default.
• W2160696211 crossrefType "journal-article" @default.
• W2160696211 hasAuthorship W2160696211A5016057578 @default.
• W2160696211 hasAuthorship W2160696211A5026377797 @default.
• W2160696211 hasAuthorship W2160696211A5034436745 @default.
• W2160696211 hasAuthorship W2160696211A5036965490 @default.
• W2160696211 hasAuthorship W2160696211A5074641512 @default.
• W2160696211 hasAuthorship W2160696211A5089583231 @default.
• W2160696211 hasBestOaLocation W21606962111 @default.
• W2160696211 hasConcept C123915805 @default.
• W2160696211 hasConcept C126322002 @default.
• W2160696211 hasConcept C134018914 @default.
• W2160696211 hasConcept C167734588 @default.
• W2160696211 hasConcept C170493617 @default.
• W2160696211 hasConcept C27016395 @default.
• W2160696211 hasConcept C2777025900 @default.
• W2160696211 hasConcept C2778271429 @default.
• W2160696211 hasConcept C2779200603 @default.
• W2160696211 hasConcept C2779479957 @default.
• W2160696211 hasConcept C2779591629 @default.
• W2160696211 hasConcept C2779611605 @default.
• W2160696211 hasConcept C2779829184 @default.
• W2160696211 hasConcept C2780036600 @default.
• W2160696211 hasConcept C2780394083 @default.
• W2160696211 hasConcept C2908929049 @default.
• W2160696211 hasConcept C555293320 @default.
• W2160696211 hasConcept C71924100 @default.
• W2160696211 hasConcept C84393581 @default.
• W2160696211 hasConceptScore W2160696211C123915805 @default.
• W2160696211 hasConceptScore W2160696211C126322002 @default.
• W2160696211 hasConceptScore W2160696211C134018914 @default.
• W2160696211 hasConceptScore W2160696211C167734588 @default.
• W2160696211 hasConceptScore W2160696211C170493617 @default.
• W2160696211 hasConceptScore W2160696211C27016395 @default.
• W2160696211 hasConceptScore W2160696211C2777025900 @default.
• W2160696211 hasConceptScore W2160696211C2778271429 @default.
• W2160696211 hasConceptScore W2160696211C2779200603 @default.
• W2160696211 hasConceptScore W2160696211C2779479957 @default.
• W2160696211 hasConceptScore W2160696211C2779591629 @default.
• W2160696211 hasConceptScore W2160696211C2779611605 @default.
• W2160696211 hasConceptScore W2160696211C2779829184 @default.
• W2160696211 hasConceptScore W2160696211C2780036600 @default.
• W2160696211 hasConceptScore W2160696211C2780394083 @default.
• W2160696211 hasConceptScore W2160696211C2908929049 @default.
• W2160696211 hasConceptScore W2160696211C555293320 @default.
• W2160696211 hasConceptScore W2160696211C71924100 @default.
• W2160696211 hasConceptScore W2160696211C84393581 @default.
• W2160696211 hasIssue "1" @default.
• W2160696211 hasLocation W21606962111 @default.
• W2160696211 hasLocation W21606962112 @default.
• W2160696211 hasOpenAccess W2160696211 @default.
• W2160696211 hasPrimaryLocation W21606962111 @default.
• W2160696211 hasRelatedWork W1524475445 @default.

• next